Institutional Knowledge Map (KMap)
Map
Services
How To Use
About
Toggle theme
Loading...
Menu
Karn Wijarnpreecha
Associate Clinical Professor, Internal Medicine
COM Phx Internal Medicine
Map Page
Research Area
meta-analysis,
systematic review,
nonalcoholic fatty liver disease,
liver disease,
risk,
mortality,
cirrhosis,
association,
united states,
risk factors,
epidemiology,
liver transplantation,
hepatitis c,
celiac disease,
fibrosis,
infection,
obesity,
patients,
cardiovascular disease,
infectious diseases,
proton pump inhibitors,
smoking,
sarcopenia,
hepatocellular carcinoma,
covid-19,
metabolic dysfunction,
trends,
venous thromboembolism,
helicobacter pylori,
outcomes
Publications
(301)
Recent
The Global Burden of Early-Onset Biliary Tract Cancer: Insight From the Global Burden of Disease Study 2019
2024
cancer,
global health,
epidemiology,
disease burden,
medical research
Financial hardshiand cost‐related nonadherence to medication in patients with liver disease in the United States
2024
medication adherence,
liver disease,
financial hardship,
healthcare cost,
united states
What Is New in Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals: From Bench to Bedside
2024
metabolic dysfunction,
steatotic liver disease,
lean individuals,
bench to bedside,
liver disease
The prevalence and predictors of metabolic dysfunction‐associated steatotic liver disease and fibrosis/cirrhosis among adolescents/young adults
2024
metabolic dysfunction,
liver disease,
adolescents,
fibrosis,
predictors
Global and Regional Burden of Alcohol-associated Liver Disease and Alcohol Use Disorder in the Elderly
2024
alcohol-associated liver disease,
alcohol use disorder,
elderly,
global burden,
regional burden
The Global Burden of Alcohol-associated Cirrhosis and Cancer in Young and Middle-aged Adults
2024
alcohol-associated diseases,
global burden,
cirrhosis,
cancer,
young adults
Rising global burden of cancer attributable to high BMI from 2010 to 2019
2024
cancer,
obesity,
global burden,
bmi,
trends
Impact of the COVID-19 pandemic on hospitalizations with hepatocellular carcinoma in the United States
2024
covid-19,
hospitalizations,
hepatocellular carcinoma,
united states,
pandemic
Proton puminhibitors increases longitudinal risk of mortality, decompensation, and infection in cirrhosis: a meta-analysis
2024
proton pump inhibitors,
cirrhosis,
mortality,
decompensation,
infection
Disparities among ethnic groups in mortality and outcomes among adults with MASLD: A multicenter study.
2024
ethnic disparities,
mortality,
outcomes,
masld
300+ Publications